Canton Hathaway’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-601
| Closed | -$25K | – | 282 |
|
|
2024
Q4 | $25K | Hold |
601
| – | – | 0.01% | 219 |
|
|
2024
Q3 | $40K | Sell |
601
-820
| -58% | -$54.6K | 0.01% | 182 |
|
|
2024
Q2 | $169K | Buy |
1,421
+820
| +136% | +$97.5K | 0.05% | 99 |
|
|
2024
Q1 | $64K | Hold |
601
| – | – | 0.02% | 138 |
|
|
2023
Q4 | $60K | Sell |
601
-370
| -38% | -$36.9K | 0.02% | 147 |
|
|
2023
Q3 | $100K | Buy |
971
+370
| +62% | +$38.1K | 0.03% | 111 |
|
|
2023
Q2 | $73K | Hold |
601
| – | – | 0.02% | 127 |
|
|
2023
Q1 | $92K | Sell |
601
-730
| -55% | -$112K | 0.03% | 113 |
|
|
2022
Q4 | $239K | Buy |
1,331
+730
| +121% | +$131K | 0.08% | 84 |
|
|
2022
Q3 | $71K | Hold |
601
| – | – | 0.03% | 133 |
|
|
2022
Q2 | $86K | Hold |
601
| – | – | 0.03% | 130 |
|
|
2022
Q1 | $104K | Hold |
601
| – | – | 0.03% | 131 |
|
|
2021
Q4 | $153K | Hold |
601
| – | – | 0.04% | 129 |
|
|
2021
Q3 | $231K | Sell |
601
-200
| -25% | -$76.9K | 0.07% | 105 |
|
|
2021
Q2 | $188K | Hold |
801
| – | – | 0.06% | 103 |
|
|
2021
Q1 | $105K | Buy |
+801
| New | +$105K | 0.03% | 132 |
|
|
2020
Q2 | – | Sell |
-8,380
| Closed | -$251K | – | 165 |
|
|
2020
Q1 | $251K | Buy |
8,380
+5,000
| +148% | +$150K | 0.18% | 54 |
|
|
2019
Q4 | $66K | Buy |
3,380
+140
| +4% | +$2.73K | 0.03% | 115 |
|
|
2019
Q3 | $52K | Sell |
3,240
-4,980
| -61% | -$79.9K | 0.03% | 118 |
|
|
2019
Q2 | $120K | Buy |
8,220
+3,610
| +78% | +$52.7K | 0.07% | 98 |
|
|
2019
Q1 | $93K | Buy |
4,610
+2,165
| +89% | +$43.7K | 0.05% | 106 |
|
|
2018
Q4 | $37K | Buy |
+2,445
| New | +$37K | 0.02% | 118 |
|